Delivering the message: How a novel technology enabled the rapid development of effective vaccines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34562362.
- Also identified by DOI 10.1016/j.cell.2021.08.019 and PMC identifier 8462133.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This year's Lasker∼Debakey Clinical Research Award honors Katalin Karikó and Drew Weissman for the development of a therapeutic technology based on nucleoside-modification of messenger RNA, enabling the rapid development of the highly effective COVID-19 vaccines.
Medical subject headings
- Biotechnology
- COVID-19
- COVID-19 Vaccines
- RNA, Messenger
- SARS-CoV-2
- Vaccines, Synthetic